Cullinan Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cullinan Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Cullinan Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.02M, a 31% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.02M -$906K -31% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.12M -$1.38M -39.4% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.34M -$1.48M -38.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.54M -$1.59M -38.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $2.93M -$1.57M -34.9% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $3.5M +$2.43M +226% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.82M +$2.63M +220% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.13M +$4.13M Dec 31, 2022 10-K 2024-03-14
Q3 2022 $4.5M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.07M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.19M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.